Owners, management and financials
CVR: 36559241
Previous names: DLI Market Intelligence ApS
DKK -67,441,461
Gross profit
Net result: DKK -66,049,966
DLI - DANSK LÆGEMIDDEL INFORMATION A/S (90-99,99%), TJELLESEN MAX JENNE A/S (10-14,99%)
CVR · view owners
Thomas Senderovitz
Board: Anja Cecilie Verhaug (chair) and 5 members
CVR · view management
Active
Founded 2 March 2015
CVR · view overview
53 employees
CVR · 2026
Director registered: Thomas Senderovitz
CVR · 12/01/2026
View the full event history
Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.
Selskabets formål er at drive virksomhed med salg af lægemiddelinformation og hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -67.4 mio. | -66 mio. | 56.7 mio. | 40.7 mio. | 43 | |
| 202401/01/2024 – 31/12/2024 | -1.9 mio. | -5.9 mio. | 125.6 mio. | 106.8 mio. | 41 | |
| 202301/01/2023 – 31/12/2023 | 1.5 mio. | -3.1 mio. | 131.5 mio. | 112.7 mio. | 41 | |
| 202201/01/2022 – 31/12/2022 | -184 t. | -11.3 mio. | 133.5 mio. | 115.8 mio. | 36 | |
| 202101/01/2021 – 31/12/2021 | 7.6 mio. | 1.3 mio. | 151 mio. | 128.5 mio. | 34 | |
| 202001/01/2020 – 31/12/2020 | 8.1 mio. | 1 mio. | 158 mio. | 128.2 mio. | 32 | |
| 201901/01/2019 – 31/12/2019 | 10.5 mio. | 3.8 mio. | 159.2 mio. | 129.2 mio. | 28 | |
| 201801/01/2018 – 31/12/2018 | 12 mio. | 4.1 mio. | 152.6 mio. | 127.5 mio. | 21 | |
| 201701/01/2017 – 31/12/2017 | 12.5 mio. | 5.5 mio. | 149 mio. | 125.8 mio. | - | |
| 201601/01/2016 – 31/12/2016 | 11.4 mio. | 4.8 mio. | 145.5 mio. | 122.5 mio. | 16 | |
| 201501/01/2015 – 31/12/2015 | 9.2 mio. | 2.6 mio. | 142.2 mio. | 119.5 mio. | 16 |
Compared to 6.302 companies in Computerkonsulentbistand og forvaltning af computerfaciliteter
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Signum Life Science ApS is 36559241.
Signum Life Science ApS is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S.
The management of Signum Life Science ApS consists of Thomas Senderovitz.
The board of Signum Life Science ApS consists of Anja Cecilie Verhaug, Mari-Ann Retz and Anne Marie Hedegaard Byskov, with Anja Cecilie Verhaug as chair.
In 2025, Signum Life Science ApS reported a gross profit of DKK -67,441,461.
Signum Life Science ApS had 53 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
As of July 1, 2026, Johannes Michael Leuchs has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2025. Gross profit came to DKK -67,441,461, and the net result was DKK -66,049,966.
As of April 17, 2026, Mari-Ann Retz has joined the board of directors of Signum Life Science ApS.
As of April 17, 2026, Johannes Michael Leuchs has joined the board of directors of Signum Life Science ApS.
As of April 17, 2026, Anja Cecilie Verhaug has joined the board of directors of Signum Life Science ApS.
As of April 17, 2026, Christian Bruun-Andersen has left the board of directors of Signum Life Science ApS.
As of April 17, 2026, Julie Enevold Brooker has left the board of directors of Signum Life Science ApS.
As of April 16, 2026, Anja Cecilie Verhaug has left the board of directors of Signum Life Science ApS.
As of January 23, 2026, Felicia Nina Ida Salicath has left the board of directors of Signum Life Science ApS.
As of January 12, 2026, Thomas Senderovitz is registered as adm. dir. of Signum Life Science ApS.
As of January 11, 2026, Henrik Vestergaard has stepped down as adm. dir. of Signum Life Science ApS.
As of October 1, 2025, Henrik Vestergaard is registered as adm. dir. of Signum Life Science ApS.
As of September 30, 2025, Ida Sofie Jensen has stepped down as adm. dir. of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2024. Gross profit came to DKK -1,866,160, and the net result was DKK -5,936,982.
As of April 14, 2025, Julie Enevold Brooker has joined the board of directors of Signum Life Science ApS.
As of April 14, 2025, Anja Cecilie Verhaug has joined the board of directors of Signum Life Science ApS.
As of April 14, 2025, Thomas Bo Bjørn Klee has left the board of directors of Signum Life Science ApS.
As of April 14, 2025, Mari-Ann Retz has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2023. Gross profit came to DKK 1,482,298, and the net result was DKK -3,084,293.
As of April 20, 2024, Søren Hvidsten Nielsen has joined the board of directors of Signum Life Science ApS.
As of April 20, 2024, Christian Bruun-Andersen has joined the board of directors of Signum Life Science ApS.
As of April 20, 2024, Felicia Nina Ida Salicath has joined the board of directors of Signum Life Science ApS.
As of April 20, 2024, Anne Marie Hedegaard Byskov has joined the board of directors of Signum Life Science ApS.
As of April 20, 2024, Anne Cathrine Falch-Jørgensen has joined the board of directors of Signum Life Science ApS.
As of April 20, 2024, Thomas Gross Nødvig has left the board of directors of Signum Life Science ApS.
As of April 20, 2024, Pia Krogsgaard Villadsen has left the board of directors of Signum Life Science ApS.
As of April 19, 2024, EY Godkendt Revisionspartnerselskab has been appointed auditor of Signum Life Science ApS.
As of April 19, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Signum Life Science ApS.
On October 31, 2023, the company changed its name from DLI Market Intelligence ApS to Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2022. Gross profit came to DKK -183,840, and the net result was DKK -11,313,396.
As of April 30, 2023, Jonas Emil Steenvinkel has left the board of directors of Signum Life Science ApS.
As of April 14, 2023, Mari-Ann Retz has joined the board of directors of Signum Life Science ApS.
As of April 14, 2023, Tore von Würden Petersen has joined the board of directors of Signum Life Science ApS.
As of April 14, 2023, Lars Møller has left the board of directors of Signum Life Science ApS.
As of April 13, 2023, Tore von Würden Petersen has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2021. Gross profit came to DKK 7,602,418, and the net result was DKK 1,317,024.
As of March 1, 2022, Jonas Emil Steenvinkel has joined the board of directors of Signum Life Science ApS.
As of March 1, 2022, Allan Karne Levisen has left the board of directors of Signum Life Science ApS.
As of February 28, 2022, Jonas Emil Steenvinkel has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2020. Gross profit came to DKK 8,099,776, and the net result was DKK 1,046,195.
As of April 8, 2021, Tore von Würden Petersen has joined the board of directors of Signum Life Science ApS.
As of February 1, 2021, Andreas Daugaard Jørgensen has left the board of directors of Signum Life Science ApS.
As of May 15, 2020, Thomas Bo Bjørn Klee has joined the board of directors of Signum Life Science ApS.
As of May 15, 2020, Lars Møller has joined the board of directors of Signum Life Science ApS.
As of May 15, 2020, Andreas Daugaard Jørgensen has joined the board of directors of Signum Life Science ApS.
As of May 14, 2020, Thomas Bo Bjørn Klee has left the board of directors of Signum Life Science ApS.
As of May 14, 2020, Lars Møller has left the board of directors of Signum Life Science ApS.
As of May 14, 2020, Andreas Daugaard Jørgensen has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2019. Gross profit came to DKK 10,457,442, and the net result was DKK 3,795,326.
As of March 30, 2020, Allan Karne Levisen has joined the board of directors of Signum Life Science ApS.
As of March 30, 2020, Cecilie Betzer has left the board of directors of Signum Life Science ApS.
As of March 29, 2020, Allan Karne Levisen has left the board of directors of Signum Life Science ApS.
As of February 28, 2020, Allan Karne Levisen has joined the board of directors of Signum Life Science ApS.
As of February 28, 2020, Cecilie Betzer has joined the board of directors of Signum Life Science ApS.
As of February 28, 2020, Jonas Emil Steenvinkel has joined the board of directors of Signum Life Science ApS.
As of February 27, 2020, Allan Karne Levisen has left the board of directors of Signum Life Science ApS.
As of November 1, 2019, Thomas Bo Bjørn Klee has joined the board of directors of Signum Life Science ApS.
As of November 1, 2019, Lars Møller has joined the board of directors of Signum Life Science ApS.
As of November 1, 2019, Mads Veggerby Lausten has left the board of directors of Signum Life Science ApS.
As of October 31, 2019, Lars Møller has left the board of directors of Signum Life Science ApS.
As of June 21, 2019, Mads Veggerby Lausten has joined the board of directors of Signum Life Science ApS.
As of June 21, 2019, Andreas Daugaard Jørgensen has joined the board of directors of Signum Life Science ApS.
As of June 21, 2019, Christoffer Dahl has left the board of directors of Signum Life Science ApS.
As of June 20, 2019, Mads Veggerby Lausten has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2018. Gross profit came to DKK 12,039,531, and the net result was DKK 4,067,570.
As of April 3, 2019, Lars Møller has joined the board of directors of Signum Life Science ApS.
As of April 3, 2019, Christina Dyreborg Jeppesen has left the board of directors of Signum Life Science ApS.
As of March 29, 2019, Thomas Gross Nødvig has joined the board of directors of Signum Life Science ApS.
As of March 28, 2019, Thomas Gross Nødvig has left the board of directors of Signum Life Science ApS.
As of November 26, 2018, Thomas Gross Nødvig has joined the board of directors of Signum Life Science ApS.
As of November 26, 2018, Christina Dyreborg Jeppesen has joined the board of directors of Signum Life Science ApS.
As of November 26, 2018, Christoffer Dahl has joined the board of directors of Signum Life Science ApS.
As of November 26, 2018, Anders Thelborg has left the board of directors of Signum Life Science ApS.
As of November 26, 2018, Henriette Rosenquist has left the board of directors of Signum Life Science ApS.
As of November 26, 2018, Julie Enevold Brooker has left the board of directors of Signum Life Science ApS.
As of November 26, 2018, Carina Schaldemose Sørensen has left the board of directors of Signum Life Science ApS.
As of November 25, 2018, Thomas Gross Nødvig has left the board of directors of Signum Life Science ApS.
As of November 25, 2018, Christina Dyreborg Jeppesen has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2017. Gross profit came to DKK 12,527,562, and the net result was DKK 5,500,937.
As of April 3, 2018, Mads Veggerby Lausten has joined the board of directors of Signum Life Science ApS.
As of November 16, 2017, Christina Dyreborg Jeppesen has joined the board of directors of Signum Life Science ApS.
As of November 16, 2017, Henriette Rosenquist has joined the board of directors of Signum Life Science ApS.
As of November 16, 2017, Julie Enevold Brooker has joined the board of directors of Signum Life Science ApS.
As of November 16, 2017, Lasse Richter Petersen has left the board of directors of Signum Life Science ApS.
As of November 16, 2017, Christophe Duret has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2016. Gross profit came to DKK 11,381,989, and the net result was DKK 4,835,572.
As of April 5, 2017, Anders Thelborg has joined the board of directors of Signum Life Science ApS.
As of April 5, 2017, Jan Fritzbøger has left the board of directors of Signum Life Science ApS.
As of April 5, 2017, Mads Tang Dalsgaard has left the board of directors of Signum Life Science ApS.
Signum Life Science ApS has published its annual report for 2015. Gross profit came to DKK 9,203,931, and the net result was DKK 2,630,535.
As of April 6, 2016, Mads Tang Dalsgaard has joined the board of directors of Signum Life Science ApS.
As of April 6, 2016, Lone Henriette Andreasen has left the board of directors of Signum Life Science ApS.
As of March 29, 2016, Thomas Gross Nødvig has joined the board of directors of Signum Life Science ApS.
As of March 29, 2016, Jan Fritzbøger has joined the board of directors of Signum Life Science ApS.
As of March 29, 2016, Christophe Duret has joined the board of directors of Signum Life Science ApS.
As of March 29, 2016, Carina Schaldemose Sørensen has joined the board of directors of Signum Life Science ApS.
As of March 29, 2016, Jan Ulrik Stevnsborg has left the board of directors of Signum Life Science ApS.
As of March 28, 2016, Thomas Gross Nødvig has left the board of directors of Signum Life Science ApS.
As of March 28, 2016, Christophe Duret has left the board of directors of Signum Life Science ApS.
As of October 30, 2015, Christophe Duret has joined the board of directors of Signum Life Science ApS.
As of March 2, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Signum Life Science ApS.
As of March 2, 2015, Thomas Gross Nødvig has joined the board of directors of Signum Life Science ApS.
As of March 2, 2015, Pia Krogsgaard Villadsen has joined the board of directors of Signum Life Science ApS.
As of March 2, 2015, Lasse Richter Petersen has joined the board of directors of Signum Life Science ApS.
As of March 2, 2015, Jan Ulrik Stevnsborg has joined the board of directors of Signum Life Science ApS.
As of March 2, 2015, Lone Henriette Andreasen has joined the board of directors of Signum Life Science ApS.
As of March 2, 2015, Allan Karne Levisen has joined the board of directors of Signum Life Science ApS.
As of March 2, 2015, Ida Sofie Jensen is registered as adm. dir. of Signum Life Science ApS.
As of March 2, 2015, DLI - DANSK LÆGEMIDDEL INFORMATION A/S is registered as an owner of Signum Life Science ApS with an ownership share of 90%.
As of March 2, 2015, TJELLESEN MAX JENNE A/S is registered as an owner of Signum Life Science ApS with an ownership share of 10%.
Signum Life Science ApS was founded on March 2, 2015.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 37357766
CVR 14576207
CVR 25281012
CVR 33062761
CVR 46284445
